OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
6
Results
Show all
Save search
Copy query
Show results for
Unknown
(6)
Publication Date
Release Date
2024
(1)
2021
(1)
2019
(1)
2017
(1)
2014
(1)
2013
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Phase 1 study of the anti-CD22 immunotoxin moxetumomab pasudotox for childhood acute lymphoblastic leukemia.
Not available
S-EPMC5630009
|
biostudies-literature
Cite
Phase I study of samalizumab in chronic lymphocytic leukemia and multiple myeloma: blockade of the immune checkpoint CD200.
Not available
S-EPMC6708181
|
biostudies-literature
Cite
Mitochondrial priming of chronic lymphocytic leukemia patients associates Bcl-xL dependence with alvocidib response.
Not available
S-EPMC4221486
|
biostudies-literature
Cite
Safety and activity of the TGFβ receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer.
Not available
S-EPMC7944986
|
biostudies-literature
Cite
Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.
Not available
S-EPMC3729927
|
biostudies-literature
Cite
Noninvasive Ventilation for Preoxygenation during Emergency Intubation.
Not available
S-EPMC11282951
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets